Hitachi Chemical licenses stem cell medium from Israel Accellta

The medium developed by Axelta can cultivate large amount of cells by floating them in a liquid medium, without using a carrier. As a result, cells can be removing cells without separation from a carrier, reducing cell damage and improving their quality. By this technical licensing, Hitachi Kasei will strengthen its technical capabilities in contract manufacturing business.

Source: Hitachi Chemical news release, February 5, 2018

Request a quote for deeper information from

© 2018 Window to Japan - Bio 4 Business - Imprint